The above article, published online on 27 July 2025 in Exploration of Targeted Anti-tumor Therapy (https://www.explorationpub.com/Journals/etat), has been retracted by agreement between the Editor-in-Chief, Nicola Normanno, and the editorial team. This retraction was prompted by issues identified with the figures in the manuscript during the journal's routine systematic self-examination.

The specific concerns uncovered are detailed below:

• Figure 4 shows an unexpected duplication between panels B and C.

• Figure 5 shows an unexpected duplication between panels B, C, and D.

• Figure 7 shows an unexpected duplication between panels “Quercetin 15.11 μg/mL, Day 3”, “MO-AgNPs 12 μg/mL, Day 8”, and “MO-AgNPs 6 μg/mL, Day 14”; “MO-AgNPs 12 μg/mL, Day 3” and “MO-AgNPs 6 μg/mL, Day 8”.

Upon identifying the issues, the journal promptly reached out to the authors, requesting a self-assessment. The authors have taken a cooperative stance by providing explanations and documents when approached for clarification, but failed to provide an adequate response to demonstrate adherence to the journal's standards. As a result, the article has been retracted with the approval of the editorial team.

All authors disagree with the retraction.